Qiagen Launches Portable Digital SARS-CoV-2 Antigen Test in the US

 Qiagen Launches Portable Digital SARS-CoV-2 Antigen Test in the US

Qiagen Launches Portable Digital SARS-CoV-2 Antigen Test in the US

Shots:

  • Qiagen has initiated the commercialization of the portable digital QIAreach SARS-CoV-2 antigen test in the US that can be used by laboratories to detect active infections in 2-15mins.
  • The test provides a higher throughput testing for SARS-CoV-2 antigen by processing up to 8 tests/ hub. The digital results do not need subjective interpretation and enable Ab tests to run simultaneously with Ag tests
  • QIAreach SARS-CoV-2 Ag test is a fast, digital, and easy to use a test that utilizes sensitive nanoparticle technology and is developed in partnership with Ellume. The company anticipate receiving CE-IVD registration for the EU and other markets by the end of 2020

Click here­ to­ read full press release/ article | Ref: Qiagen | Image: Holland One

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post